Chargement en cours...
Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease
Background and objectives: Recently, we showed that soluble TNF-like weak inducer of apoptosis (sTWEAK) plasma levels are diminished in hemodialysis patients and had additive effects with IL-6 on survival. Because sTWEAK plasma level has been associated with the presence of chronic kidney disease (C...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Nephrology
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2774962/ https://ncbi.nlm.nih.gov/pubmed/19820131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.02760409 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|